Boston Scientific posts net loss on charges, weaker sales

Thu Oct 18, 2012 7:19am EDT

* Third-qtr net loss 52 cents vs profit 9 cents

* Excluding items, profit 16 cents vs Wall St view of 11 cents

* Sales fall to $1.735 bln from $1.874 bln

Oct 18 (Reuters) - Medical device maker Boston Scientific Corp on Thursday reported a quarterly net loss on charges and weaker sales.

Net earnings were $725 million, or 52 cents per share in the third quarter, compared with a net profit of $142 million, or 9 cents per share, in the year-ago period.

Excluding items, the company posted a profit of 16 cents. On that basis, the average estimate on Wall Street was 11 cents.

Quarterly sales were $1.735 billion, down from $1.874 billion a year ago.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.